MacLean, C.M.; Ulys, A.; Jankevičius, F.; Saladžinskas, Ž.; van Os, S.; Larsen, F.
Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies. Medicina 2023, 59, 681.
https://doi.org/10.3390/medicina59040681
AMA Style
MacLean CM, Ulys A, Jankevičius F, Saladžinskas Ž, van Os S, Larsen F.
Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies. Medicina. 2023; 59(4):681.
https://doi.org/10.3390/medicina59040681
Chicago/Turabian Style
MacLean, Carol M., Albertas Ulys, Feliksas Jankevičius, Žilvinas Saladžinskas, Steve van Os, and Finn Larsen.
2023. "Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies" Medicina 59, no. 4: 681.
https://doi.org/10.3390/medicina59040681
APA Style
MacLean, C. M., Ulys, A., Jankevičius, F., Saladžinskas, Ž., van Os, S., & Larsen, F.
(2023). Safety, Pharmacokinetic and Pharmacodynamic Evaluation of Teverelix for the Treatment of Hormone-Sensitive Advanced Prostate Cancer: Phase 2 Loading-Dose-Finding Studies. Medicina, 59(4), 681.
https://doi.org/10.3390/medicina59040681